Harvard Medical School has created more wiggle room in one of its conflict-of-interest rules, after complaints from professors that the policy was hampering them from turning lab discoveries into treatments that could help people. Eric Campbell (Mass General) and Donald Ingber (Wyss Institute) are quoted, and Jeffrey S. Flier (HMS dean) and Robert Mayer (Brigham and Women’s/Dana-Farber) are mentioned.
News & Research
